Have a feature idea you'd love to see implemented?
Let us know!
XBIT XBiotech Inc
Price (delayed)
$6.83
Market cap
$208.2M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.08
Enterprise value
$35.08M
XBiotech is a fully integrated, global biopharmaceutical company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies. XBiotech currently is advancing a pipeline of therapies by harnessing naturally
Highlights
XBIT's quick ratio has dropped by 70% year-on-year but it is up by 4.1% since the previous quarter
XBiotech's EPS has decreased by 42% YoY but it has increased by 7% QoQ
XBIT's gross profit has dropped by 100% year-on-year
XBIT's revenue has dropped by 100% year-on-year
Key stats
What are the main financial stats of XBIT
Market
Valuations
Earnings
Shares outstanding
30.48M
Market cap
$208.2M
Enterprise value
$35.08M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.08
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$32.55M
EBITDA
-$30.81M
Free cash flow
-$29.19M
Per share
Balance sheet
Liquidity
EPS
-$1.08
Free cash flow per share
-$0.96
Book value per share
$6.31
Revenue per share
$0
TBVPS
$6.89
Total assets
$209.85M
Total liabilities
$17.74M
Debt
$10M
Equity
$192.12M
Working capital
$169.04M
Debt to equity
0.05
Current ratio
11.57
Quick ratio
11.45
Net debt/EBITDA
5.62
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-14.8%
Return on equity
-16%
Return on invested capital
-160.6%
Return on capital employed
-16.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
XBIT stock price
How has the XBiotech stock price performed over time
Intraday
3.17%
1 week
2.55%
1 month
-9.05%
1 year
90.78%
YTD
70.75%
QTD
-11.64%
Financial performance
How have XBiotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$42.31M
Net income
-$32.66M
Gross margin
N/A
Net margin
N/A
XBIT's gross profit has dropped by 100% year-on-year
XBIT's revenue has dropped by 100% year-on-year
XBiotech's net income has decreased by 41% YoY but it has increased by 7% from the previous quarter
The company's operating income fell by 14% YoY
Growth
What is XBiotech's growth rate over time
Valuation
What is XBiotech stock price valuation
P/E
N/A
P/B
1.08
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
XBiotech's EPS has decreased by 42% YoY but it has increased by 7% QoQ
The P/B is 20% higher than the last 4 quarters average of 0.9 and 8% higher than the 5-year quarterly average of 1.0
The equity has declined by 14% year-on-year and by 2.3% since the previous quarter
XBIT's revenue has dropped by 100% year-on-year
Efficiency
How efficient is XBiotech business performance
The return on equity has dropped by 60% year-on-year but it rose by 3% since the previous quarter
XBIT's ROA has shrunk by 53% YoY but it is up by 5% QoQ
XBIT's ROIC is up by 4.9% QoQ
Dividends
What is XBIT's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did XBiotech financials performed over time
XBIT's total liabilities has soared by 156% year-on-year but it is down by 6% since the previous quarter
The current ratio has plunged by 70% YoY but it has grown by 4% from the previous quarter
The debt is 95% lower than the equity
The equity has declined by 14% year-on-year and by 2.3% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.